Rankings
▼
Calendar
SMMT Q1 2020 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
SMMT
Summit Therapeutics Inc.
$12B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$324,000
Gross Profit
$386,291
119.2% margin
Operating Income
-$9M
-2882.7% margin
Net Income
-$6M
-1893.2% margin
EPS (Diluted)
$-0.11
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$366,591
Balance Sheet
Total Assets
$110M
Total Liabilities
$26M
Stockholders' Equity
$83M
Cash & Equivalents
$68M
← FY 2020
All Quarters
Q2 2020 →
